154 related articles for article (PubMed ID: 34355905)
1. Modulation of a Mycobacterial ADP-Ribosyltransferase to Augment Rifamycin Antibiotic Resistance.
Zheng M; Lupoli TJ
ACS Infect Dis; 2021 Sep; 7(9):2604-2611. PubMed ID: 34355905
[TBL] [Abstract][Full Text] [Related]
2. Kanglemycin A Can Overcome Rifamycin Resistance Caused by ADP-Ribosylation by Arr Protein.
Harbottle J; Mosaei H; Allenby N; Zenkin N
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0086421. PubMed ID: 34606341
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic rifamycin resistance of Mycobacterium abscessus is mediated by ADP-ribosyltransferase MAB_0591.
Rominski A; Roditscheff A; Selchow P; Böttger EC; Sander P
J Antimicrob Chemother; 2017 Feb; 72(2):376-384. PubMed ID: 27999011
[TBL] [Abstract][Full Text] [Related]
4. Rifamycin antibiotic resistance by ADP-ribosylation: Structure and diversity of Arr.
Baysarowich J; Koteva K; Hughes DW; Ejim L; Griffiths E; Zhang K; Junop M; Wright GD
Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4886-91. PubMed ID: 18349144
[TBL] [Abstract][Full Text] [Related]
5. Species-Specific Interactions of Arr with RplK Mediate Stringent Response in Bacteria.
Agrawal P; Varada R; Sah S; Bhattacharyya S; Varshney U
J Bacteriol; 2018 Mar; 200(6):. PubMed ID: 29311276
[TBL] [Abstract][Full Text] [Related]
6. Rifabutin Is Inactivated by Mycobacterium abscessus Arr.
Schäfle D; Selchow P; Borer B; Meuli M; Rominski A; Schulthess B; Sander P
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318008
[No Abstract] [Full Text] [Related]
7. Blocking Bacterial Naphthohydroquinone Oxidation and ADP-Ribosylation Improves Activity of Rifamycins against Mycobacterium abscessus.
Ganapathy US; Lan T; Krastel P; Lindman M; Zimmerman MD; Ho H; Sarathy JP; Evans JC; Dartois V; Aldrich CC; Dick T
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0097821. PubMed ID: 34228543
[TBL] [Abstract][Full Text] [Related]
8. Redesign of Rifamycin Antibiotics to Overcome ADP-Ribosylation-Mediated Resistance.
Lan T; Ganapathy US; Sharma S; Ahn YM; Zimmerman M; Molodtsov V; Hegde P; Gengenbacher M; Ebright RH; Dartois V; Freundlich JS; Dick T; Aldrich CC
Angew Chem Int Ed Engl; 2022 Nov; 61(45):e202211498. PubMed ID: 36222275
[TBL] [Abstract][Full Text] [Related]
9. Genomic epidemiology of rifampicin ADP-ribosyltransferase (Arr) in the Bacteria domain.
Morgado S; Fonseca É; Vicente AC
Sci Rep; 2021 Oct; 11(1):19775. PubMed ID: 34611248
[TBL] [Abstract][Full Text] [Related]
10. Blocking ADP-ribosylation expands the anti-mycobacterial spectrum of rifamycins.
Ganapathy US; Lan T; Dartois V; Aldrich CC; Dick T
Microbiol Spectr; 2023 Sep; 11(5):e0190023. PubMed ID: 37681986
[TBL] [Abstract][Full Text] [Related]
11. The Enzymes of the Rifamycin Antibiotic Resistome.
Surette MD; Spanogiannopoulos P; Wright GD
Acc Chem Res; 2021 May; 54(9):2065-2075. PubMed ID: 33877820
[TBL] [Abstract][Full Text] [Related]
12. New C25 carbamate rifamycin derivatives are resistant to inactivation by ADP-ribosyl transferases.
Combrink KD; Denton DA; Harran S; Ma Z; Chapo K; Yan D; Bonventre E; Roche ED; Doyle TB; Robertson GT; Lynch AS
Bioorg Med Chem Lett; 2007 Jan; 17(2):522-6. PubMed ID: 17070048
[TBL] [Abstract][Full Text] [Related]
13. Use of Mycobacterium smegmatis deficient in ADP-ribosyltransferase as surrogate for Mycobacterium tuberculosis in drug testing and mutation analysis.
Agrawal P; Miryala S; Varshney U
PLoS One; 2015; 10(4):e0122076. PubMed ID: 25874691
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium abscessus HelR interacts with RNA polymerase to confer intrinsic rifamycin resistance.
Hurst-Hess KR; Saxena A; Rudra P; Yang Y; Ghosh P
Mol Cell; 2022 Sep; 82(17):3166-3177.e5. PubMed ID: 35905736
[TBL] [Abstract][Full Text] [Related]
15. Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro.
Gill SK; Garcia GA
Tuberculosis (Edinb); 2011 Sep; 91(5):361-9. PubMed ID: 21704562
[TBL] [Abstract][Full Text] [Related]
16. HelR is a helicase-like protein that protects RNA polymerase from rifamycin antibiotics.
Surette MD; Waglechner N; Koteva K; Wright GD
Mol Cell; 2022 Sep; 82(17):3151-3165.e9. PubMed ID: 35907401
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin.
Woodley CL; Kilburn JO
Am Rev Respir Dis; 1982 Sep; 126(3):586-7. PubMed ID: 6289711
[TBL] [Abstract][Full Text] [Related]
18. Catalytic and non-catalytic roles for the mono-ADP-ribosyltransferase Arr in the mycobacterial DNA damage response.
Stallings CL; Chu L; Li LX; Glickman MS
PLoS One; 2011; 6(7):e21807. PubMed ID: 21789183
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of rifamycins for M. smegmatis with comparison of oxidation and binding to tear lipocalin.
Staudinger T; Redl B; Glasgow BJ
Biochim Biophys Acta; 2014 Apr; 1844(4):750-8. PubMed ID: 24530503
[TBL] [Abstract][Full Text] [Related]
20. A rifampin-hypersensitive mutant reveals differences between strains of Mycobacterium smegmatis and presence of a novel transposon, IS1623.
Alexander DC; Jones JR; Liu J
Antimicrob Agents Chemother; 2003 Oct; 47(10):3208-13. PubMed ID: 14506032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
